The importance of clinician engagement in the HTA process


About the Webinar:

The slides for this webinar can be viewed at our Slideshare account. 

Join Alexandra Chambers & oncologist Dr. Craig Earle with CADTH’s pan-Canadian Oncology Drug Review (pCODR) as they discuss the opportunities for clinicians to participate in the process and be part of the system, and how clinician input can help to inform cancer drug funding recommendations to enhance patient outcomes for Canadians.

3Sixty Public Affairs’ Bill Dempster moderated this interactive webinar that included opportunities for participants to participate in polling and ask questions.

About the Presenters:

Bill Dempster, CEO of 3Sixty Public Affairs, is a seasoned health and pharmaceutical policy expert who works with a range of clients to navigate complex political, policy, regulatory and reimbursement challenges.

Alexandra Chambers is the Director of the pan-Canadian Oncology Drug Review (pCODR) at CADTH.

Dr. Craig Earle Dr. Craig Earle is a medical oncologist at Sunnybrook’s Odette Cancer Centre in Toronto, Vice-President of Cancer Control at the Canadian Partnership Against Cancer, a Senior Scientist at the Institute for Clinical Evaluative Sciences, and a Professor of Medicine at the University of Toronto.